FindTrial
Sign In

Mid- and long-term clinical efficacy of surgical treatment of Vancouver B2?3-type femoral periprosthetic fracture

Mid- and long-term clinical efficacy of surgical treatment of Vancouver B2?3-type femoral periprosthetic fracture

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023940
Enrollment
Unknown
Registered
2019-06-19
Start date
2019-06-20
Completion date
Unknown
Last updated
2019-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral periprosthetic fracture

Interventions

1:Hip revision
2:Hip revision + allogeneic bone plate

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Our department of surgery for the treatment of patients with periprosthetic fractures after hip replacement; 2. Vancouver type B periprosthetic fractures; 3 unilateral surgery; 4 were completed by undergraduate senior physicians.

Exclusion criteria

Exclusion criteria: 1. No follow-up data; 2 patients with bone malformation; 3 patients with pathological fractures caused by tumor or long-term steroid administration; 4. patients with acetabular prosthesis fractures.

Design outcomes

Primary

MeasureTime frame
operation time;Blood loss;VAS;Harris score;survival analysis;complications;Hemoglobin;—

Countries

China

Contacts

Public ContactXiangyang Chen

Affiliated Hospital of Xuzhou Medical University

1173503735@qq.com+86 15905201635

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026